|
Real-time Estimate
Cboe Europe
08:07:04 2026-11-12 EST
|
5-day change | 1st Jan Change | ||
| 134.45 CHF | +1.29% |
|
+0.33% | +22.77% |
| 11-11 | Novartis AG : Jefferies gives a Neutral rating | ZD |
| 11-11 | Amgen's Sjogren's drug cuts disease activity in trial | RE |
| Market Cap | 301B 271B 251B 227B 429B 28,237B 439B 3,004B 1,197B 15,123B 1,130B 1,106B 48,126B | P/E 2026 * |
23.9x | P/E 2027 * | 18.8x |
|---|---|---|---|---|---|
| Enterprise Value | 335B 302B 279B 252B 477B 31,443B 489B 3,346B 1,333B 16,840B 1,258B 1,231B 53,589B | EV / Sales 2026 * |
5.8x | EV / Sales 2027 * | 5.34x |
| Free-Float |
91.66% | Yield 2026 * |
2.74% | Yield 2027 * | 2.88% |
| Markets | Quality | ||
|---|---|---|---|
Swiss Exchange
| NOVN | Delayed | |
OTC Markets
| NVSEF | Delayed | |
|
CBOE
| 0QLR | Real-time | |
|
Borsa Italiana
| 1NOVN | End-of-day quote | |
|
Tradegate
| NOT | Real-time | |
|
Deutsche Boerse AG
| NOT | End-of-day quote | |
|
Xetra
| NOT | End-of-day quote | |
|
Deutsche Boerse AG
| NOT | Delayed | |
|
London S.E.
| 0QLR | Delayed | |
|
Xetra
| NOT | Delayed | |
|
Boerse Muenchen
| NOT | Real-time | |
|
CBOE
| Real-time | ||
|
Mexican S.E.
| NOVN N | End-of-day quote | |
|
Börse Stuttgart
| NOT | Delayed | |
|
CBOE
| 0QLR | Real-time | |
|
Wiener Boerse
| NOVN | End-of-day quote |
Last Transcript: Novartis AG
| 1 day | +1.30% | ||
| 1 week | +0.39% | ||
| Current month | +0.64% | ||
| 1 month | +12.24% | ||
| 3 months | +8.41% | ||
| 6 months | +16.17% | ||
| Current year | +22.85% |
| 1 week | 130.1 |  | 135.08 |
| 1 month | 118.58 | | 135.22 |
| Current year | 107.68 | | 135.22 |
| 1 year | 99.45 | | 135.22 |
| 3 years | 81.1 | | 135.22 |
| 5 years | 72.84 | | 135.22 |
| 10 years | 65.09 | | 135.22 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 2018-01-31 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 2026-03-15 |
Karen Hale
CMP | Compliance Officer | 58 | 2025-04-13 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 67 | 2014-12-31 |
| Director/Board Member | 69 | 2015-12-31 | |
Ton Büchner
BRD | Director/Board Member | 61 | 2015-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/18/26 | Sell | -5,200 | 0.0003% | |||
| 5/4/26 | Sell | 6,800 | 0.0003% | |||
| 2/17/26 | Sell | 30,743 | 0.0015% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.30% | +0.39% | +28.60% | +59.11% | 301B | |
| +0.35% | +1.36% | +45.38% | +140.47% | 1,280B | |
| -0.13% | +1.48% | +44.67% | +90.43% | 675B | |
| +0.37% | +0.05% | +31.00% | +112.84% | 521B | |
| +1.06% | +3.60% | +39.74% | +69.97% | 386B | |
| -0.59% | -2.11% | +61.83% | +45.16% | 363B | |
| +0.94% | -0.13% | +3.74% | +36.85% | 286B | |
| +0.62% | -2.17% | +38.31% | +75.12% | 253B | |
| -0.67% | -2.72% | +38.49% | +123.56% | 211B | |
| +2.26% | +2.91% | -13.05% | -59.75% | 178B | |
| Average | +0.88% | -0.90% | +31.87% | +69.38% | 445B | |
| Weighted average by Cap. | +1.03% | +0.02% | +37.56% | +91.09% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 57.82B 52.11B 48.15B 43.53B 82.35B 5,423B 84.38B 577B 230B 2,904B 217B 212B 9,243B | 61.8B 55.7B 51.46B 46.52B 88.01B 5,796B 90.18B 617B 246B 3,104B 232B 227B 9,879B |
| Net income | 12.75B 11.49B 10.61B 9.6B 18.15B 1,196B 18.6B 127B 50.7B 640B 47.84B 46.82B 2,038B | 15.68B 14.14B 13.06B 11.81B 22.34B 1,471B 22.89B 157B 62.38B 788B 58.86B 57.61B 2,507B |
| Net Debt | 34.18B 30.8B 28.46B 25.73B 48.67B 3,205B 49.87B 341B 136B 1,717B 128B 126B 5,463B | 28.37B 25.57B 23.62B 21.36B 40.4B 2,661B 41.4B 283B 113B 1,425B 106B 104B 4,535B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-12 | CHF 134.58 | +1.39% | 622,157 |
| 26-11-11 | CHF 132.74 | -1.29% | 3,528,282 |
| 26-11-10 | CHF 134.48 | +0.76% | 2,544,288 |
| 26-11-09 | CHF 133.46 | +0.29% | 2,175,758 |
| 26-11-06 | CHF 133.08 | -0.78% | 4,011,966 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- NOVN Stock
Select your edition
All financial news and data tailored to specific country editions
